Investing Ideas
/
Polish Pharmaceuticals & Biotech Sustainable Track Record

Polish Pharmaceuticals & Biotech Sustainable Track Record

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.

1 companies

Genomed Spólka Akcyjna

Market Cap: zł39.6m

Provides DNA and RNA sequencing and analysis and diagnostics services for congenital diseases in Poland.

GEN

zł30.00

-0.7%

17.2%